These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 27207422)
1. The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies. Nickel KF; Labberton L; Long AT; Langer F; Fuchs TA; Stavrou EX; Butler LM; Renné T Thromb Res; 2016 May; 141 Suppl 2():S4-7. PubMed ID: 27207422 [TBL] [Abstract][Full Text] [Related]
2. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis. Nickel KF; Ronquist G; Langer F; Labberton L; Fuchs TA; Bokemeyer C; Sauter G; Graefen M; Mackman N; Stavrou EX; Ronquist G; Renné T Blood; 2015 Sep; 126(11):1379-89. PubMed ID: 26153520 [TBL] [Abstract][Full Text] [Related]
3. Platelet polyphosphates: the nexus of primary and secondary hemostasis. Müller F; Renné T Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010 [TBL] [Abstract][Full Text] [Related]
4. New agents for thromboprotection. A role for factor XII and XIIa inhibition. Labberton L; Kenne E; Renné T Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114 [TBL] [Abstract][Full Text] [Related]
5. Coagulation factor XII in thrombosis and inflammation. Maas C; Renné T Blood; 2018 Apr; 131(17):1903-1909. PubMed ID: 29483100 [TBL] [Abstract][Full Text] [Related]
6. Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection. Labberton L; Kenne E; Long AT; Nickel KF; Di Gennaro A; Rigg RA; Hernandez JS; Butler L; Maas C; Stavrou EX; Renné T Nat Commun; 2016 Sep; 7():12616. PubMed ID: 27596064 [TBL] [Abstract][Full Text] [Related]
7. Factor XI and XII as antithrombotic targets. Müller F; Gailani D; Renné T Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835 [TBL] [Abstract][Full Text] [Related]
8. Factor XI and factor XII as targets for new anticoagulants. Weitz JI Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423 [TBL] [Abstract][Full Text] [Related]
9. Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate. Mailer RK; Allende M; Heestermans M; Schweizer M; Deppermann C; Frye M; Pula G; Odeberg J; Gelderblom M; Rose-John S; Sickmann A; Blankenberg S; Huber TB; Kubisch C; Maas C; Gambaryan S; Firsov D; Stavrou EX; Butler LM; Renné T Blood; 2021 Mar; 137(10):1392-1405. PubMed ID: 32932519 [TBL] [Abstract][Full Text] [Related]
10. Role of current and emerging antithrombotics in thrombosis and cancer. Mousa SA Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996 [TBL] [Abstract][Full Text] [Related]
11. Factor XII: a novel target for safe prevention of thrombosis and inflammation. Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901 [TBL] [Abstract][Full Text] [Related]
12. Polyphosphate nanoparticles on the platelet surface trigger contact system activation. Verhoef JJ; Barendrecht AD; Nickel KF; Dijkxhoorn K; Kenne E; Labberton L; McCarty OJ; Schiffelers R; Heijnen HF; Hendrickx AP; Schellekens H; Fens MH; de Maat S; Renné T; Maas C Blood; 2017 Mar; 129(12):1707-1717. PubMed ID: 28049643 [TBL] [Abstract][Full Text] [Related]
13. Intrinsic pathway of coagulation and arterial thrombosis. Gailani D; Renné T Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770 [TBL] [Abstract][Full Text] [Related]
14. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases. Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692 [TBL] [Abstract][Full Text] [Related]
15. An Update on Safe Anticoagulation. Mailer RK; Kuta P; Renné T Hamostaseologie; 2022 Feb; 42(1):65-72. PubMed ID: 35196732 [TBL] [Abstract][Full Text] [Related]
16. Contact system revisited: an interface between inflammation, coagulation, and innate immunity. Long AT; Kenne E; Jung R; Fuchs TA; Renné T J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513 [TBL] [Abstract][Full Text] [Related]
17. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Müller F; Mutch NJ; Schenk WA; Smith SA; Esterl L; Spronk HM; Schmidbauer S; Gahl WA; Morrissey JH; Renné T Cell; 2009 Dec; 139(6):1143-56. PubMed ID: 20005807 [TBL] [Abstract][Full Text] [Related]
18. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Hillis C; Crowther MA Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149 [TBL] [Abstract][Full Text] [Related]
19. A hypothesis about how to achieve anticoagulation without bleeding. Eggers AE Med Hypotheses; 2015 Dec; 85(6):720-2. PubMed ID: 26527494 [TBL] [Abstract][Full Text] [Related]
20. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis. Spronk HMH; Padro T; Siland JE; Prochaska JH; Winters J; van der Wal AC; Posthuma JJ; Lowe G; d'Alessandro E; Wenzel P; Coenen DM; Reitsma PH; Ruf W; van Gorp RH; Koenen RR; Vajen T; Alshaikh NA; Wolberg AS; Macrae FL; Asquith N; Heemskerk J; Heinzmann A; Moorlag M; Mackman N; van der Meijden P; Meijers JCM; Heestermans M; Renné T; Dólleman S; Chayouâ W; Ariëns RAS; Baaten CC; Nagy M; Kuliopulos A; Posma JJ; Harrison P; Vries MJ; Crijns HJGM; Dudink EAMP; Buller HR; Henskens YMC; Själander A; Zwaveling S; Erküner O; Eikelboom JW; Gulpen A; Peeters FECM; Douxfils J; Olie RH; Baglin T; Leader A; Schotten U; Scaf B; van Beusekom HMM; Mosnier LO; van der Vorm L; Declerck P; Visser M; Dippel DWJ; Strijbis VJ; Pertiwi K; Ten Cate-Hoek AJ; Ten Cate H Thromb Haemost; 2018 Feb; 118(2):229-250. PubMed ID: 29378352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]